Location History:
- Tel Aviv Jaffa, IL (2022)
- Tel Aviv, IL (2021 - 2023)
Company Filing History:
Years Active: 2021-2023
Title: Hadas Zur: Innovator in Viral Research
Introduction
Hadas Zur is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of viral research, holding a total of 4 patents. Her work focuses on the design and development of attenuated viruses and polynucleotide sequences, which have important implications for biotechnology and medicine.
Latest Patents
Hadas Zur's latest patents include innovative methods for designing attenuated viruses. One of her notable patents is titled "Attenuated virus mutated at sites of evolutionarily conserved RNA structure." This patent discloses methods for creating an attenuated form of a virulent virus by altering the RNA structure at specific conserved sites. This alteration leads to the attenuation of the virus, making it less harmful while retaining its potential for research and therapeutic applications. Another significant patent is "Method and system for designing polynucleotide sequences and polynucleotide sequences obtained thereby." This patent provides methods for designing polynucleotide sequences that express polypeptides of interest in cells, along with artificial transcript sequences generated through these methods.
Career Highlights
Hadas Zur has worked with notable organizations such as Ramot at Tel Aviv University Ltd. and Yeda Research and Development Co. Ltd. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Hadas has collaborated with esteemed colleagues, including Tamir Tuller and Eli Goz. These collaborations have further enriched her research and innovation in the field of viral studies.
Conclusion
Hadas Zur is a trailblazer in the realm of viral research, with a focus on designing attenuated viruses and polynucleotide sequences. Her contributions through her patents and collaborations highlight her commitment to advancing scientific knowledge and innovation.